Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiebke Rösler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Thoracic and Cardiovascular Surgeon Reports|July 7, 2018
Primary Cardiac B-Non-Hodgkin Lymphoma Disguised as a Pacemaker EndocarditisFelix Fleißner, Ulrich Molitoris, Wiebke Rösler, et al.
Praxis|April 12, 2023
[Benefit of a Geriatric Evaluation before Operations, Interventions and Oncological Therapies]Michael Gagesch, Wiebke Rösler, Robert Bauernschmitt, et al.
International Journal of Clinical Pharmacy|September 25, 2025
Association of potentially inappropriate medications with rehospitalisation and death within three months in older patients: a systematic review and meta-analysisIsabella Muzzarelli, Vera Isabel Neumeier, Michael Gagesch, et al.
Swiss Medical Weekly|June 26, 2022
Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in SwitzerlandSebastian Stolz, Marco Roncador, Wiebke Rösler, et al.
British Journal of Haematology|July 8, 2024
Efficacy of thrombopoietin receptor agonists versus rituximab in non-responsive immune thrombocytopenia-A single centre retrospective analysisSebastian M Stolz, Rahel Schwotzer, Wiebke Rösler, et al.
Annals of Hematology|December 9, 2022
BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2Judith Konrat, Wiebke Rösler, Michael Roiss, et al.
International Journal of Cancer|April 30, 2025
Tyrosine kinase inhibitors with blinatumomab versus chemotherapy in Philadelphia-positive acute B-lymphoblastic leukemiaSebastian M Stolz, Kevin D Hofer, Wiebke Rösler, et al.
Frontiers in Oncology|August 29, 2025
Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patientsSteven Pierre Hiltgen, Heike A Bischoff-Ferrari, Michael Gagesch, et al.
Annals of Hematology|July 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patientsSebastian M Stolz, Albulena Musa, Adrian Bachofner, et al.
Radiation Oncology (London, England)|April 1, 2026
Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center studySebastian M Stolz, Camilla von Wachter, Jonas Willmann, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Thoracic and Cardiovascular Surgeon Reports|July 7, 2018
Primary Cardiac B-Non-Hodgkin Lymphoma Disguised as a Pacemaker EndocarditisFelix Fleißner, Ulrich Molitoris, Wiebke Rösler, et al.
Praxis|April 12, 2023
[Benefit of a Geriatric Evaluation before Operations, Interventions and Oncological Therapies]Michael Gagesch, Wiebke Rösler, Robert Bauernschmitt, et al.
International Journal of Clinical Pharmacy|September 25, 2025
Association of potentially inappropriate medications with rehospitalisation and death within three months in older patients: a systematic review and meta-analysisIsabella Muzzarelli, Vera Isabel Neumeier, Michael Gagesch, et al.
Swiss Medical Weekly|June 26, 2022
Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in SwitzerlandSebastian Stolz, Marco Roncador, Wiebke Rösler, et al.
British Journal of Haematology|July 8, 2024
Efficacy of thrombopoietin receptor agonists versus rituximab in non-responsive immune thrombocytopenia-A single centre retrospective analysisSebastian M Stolz, Rahel Schwotzer, Wiebke Rösler, et al.
Annals of Hematology|December 9, 2022
BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2Judith Konrat, Wiebke Rösler, Michael Roiss, et al.
International Journal of Cancer|April 30, 2025
Tyrosine kinase inhibitors with blinatumomab versus chemotherapy in Philadelphia-positive acute B-lymphoblastic leukemiaSebastian M Stolz, Kevin D Hofer, Wiebke Rösler, et al.
Frontiers in Oncology|August 29, 2025
Implementing comprehensive geriatric assessment in an academic hematologic outpatient setting: experiences from medical doctors and patientsSteven Pierre Hiltgen, Heike A Bischoff-Ferrari, Michael Gagesch, et al.
Annals of Hematology|July 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patientsSebastian M Stolz, Albulena Musa, Adrian Bachofner, et al.
Radiation Oncology (London, England)|April 1, 2026
Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center studySebastian M Stolz, Camilla von Wachter, Jonas Willmann, et al.
Pageof 2